Skip to main content

Animations

MJFF Publications

6931 - 6940 of 8826 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: Gene therapy device-based delivery of progranulin, prosaposin, and GDNF as a combined precision and neurorestorative therapy in the rat 6-OHDA model of parkinsonism
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2025.115474
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Application of new biologic disease criteria for synucleinopathies to the systemic synuclein sampling study cohort
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41531-025-00919-y
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Systematic review and consensus conceptual model of meaningful symptoms and functional impacts in early Parkinson’s Disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41531-025-00907-2
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Deep-learning segmentation of the substantia nigra from multiparametric MRI: Application to Parkinson’s disease
    Journal Name: Imaging Neuroscience
    Publisher: MIT Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1162/imag.a.158
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Pre-symptomatic Parkinson’s disease blood test quantifying repetitive sequence motifs in transfer RNA fragments
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-025-00851-z
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Exploring [11C]CPPC as a CSF1R-targeted PET imaging marker for early Parkinson’s disease severity
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1172/jci186591
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Development of a simplified smell test to identify Parkinson’s disease using multiple cohorts, machine learning and item response theory
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41531-025-00904-5
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Relationships between neuropsychiatric symptoms, subtypes of astrocyte activities, and brain pathologies in Alzheimer's disease and Parkinson's disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.70242
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Alzheimer's disease traits in Parkinson's disease without α‐synuclein seeding
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.70284
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Neuronal α‐Synuclein Disease Stage Progression over 5 Years
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.30191
    Citation Count: 10
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.